These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6543124)

  • 1. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New antiarrhythmia agents: propafenone and flecainide].
    Leclercq JF
    Presse Med; 1985 Mar; 14(12):685-9. PubMed ID: 3157964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
    Delgado C; Tamargo J; Tejerina T
    Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
    Boucher M; Chassaing C; Hamel JD; Poirier JM
    Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA; Stiles GL; Shand DG
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
    Ledda F; Mantelli L; Manzini S; Amerini S; Mugelli A
    J Cardiovasc Pharmacol; 1981; 3(6):1162-73. PubMed ID: 6173515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC; Dittrich P; Kukovetz WR
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
    Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations to characterize a new antiarrhythmic drug bisaramil.
    Paroczai M; Karpati E
    Pharmacol Res; 1991 Aug; 24(2):149-62. PubMed ID: 1684242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic activity of 17 beta-aminoestratrienes. Comparison of 3-ols and 3-acetates with the corresponding 3-(3-amino-2-hydroxypropyl) ethers.
    Campbell JK; Logan RT; Marshall RJ; McGarry G; Sleigh T; Winslow E
    J Med Chem; 1986 Feb; 29(2):244-50. PubMed ID: 3005568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
    Hapke HJ; Prigge E
    Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic activity of the local anaesthetic fomocaine and some of its analogues.
    Bräunig B; Busch AE; Mutschler E; Wess J; Oelschläger H
    Arzneimittelforschung; 1989 Nov; 39(11):1436-9. PubMed ID: 2619777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.
    Thompson KA; Iansmith DH; Siddoway LA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1988 Mar; 244(3):950-5. PubMed ID: 3252042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient outward current inhibition by propafenone and 5-hydroxypropafenone in cultured neonatal rat ventricular myocytes.
    Cahill SA; Kirshenbaum LA; Gross GJ
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):460-7. PubMed ID: 11486250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
    Winslow E; Campbell JK; Barron E; Marshall RJ; Muir AW
    Br J Pharmacol; 1991 Dec; 104(4):853-8. PubMed ID: 1810599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaco-toxicologic evaluation of newly synthesized analogs of propafenone].
    Tumová I; Racanská E; Csöllei J; Ecker G; Otrusník R; Svec P
    Ceska Slov Farm; 1997 Jun; 46(3):133-6. PubMed ID: 9440950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug profile of new benzofurane derivatives in guinea-pig isolated heart muscle preparations.
    Lemmens Gruber R; Studenik C; Marei H; Heistracher P
    Arch Int Pharmacodyn Ther; 1995; 330(2):165-76. PubMed ID: 8861710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.